Synthesis and characterization of a fluvastatin-releasing hydrogel delivery system to modulate hMSC differentiation and function for bone regeneration
Authors:
- Danielle S.W. BenoitDBDanielle S.W. Benoit
- Charles R. NuttelmanCNCharles R. Nuttelman
- Stuart D. CollinsSCStuart D. Collins
- Kristi S. AnsethKAKristi S. Anseth
- 1 December 2006
- journal article
- Published by Elsevier in Biomaterials
- Vol. 27 (36) , 6102-6110
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- A novel osteotropic biomaterial OG‐PLG: Synthesis and in vitro releaseJournal of Biomedical Materials Research Part A, 2005
- RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2 FOR TREATMENT OF OPEN TIBIAL FRACTURESJournal of Bone and Joint Surgery, 2002
- Simvastatin Promotes Osteoblast Differentiation and Mineralization in MC3T3-E1 CellsBiochemical and Biophysical Research Communications, 2001
- HMG-CoA Reductase Inhibitors and the Risk of FracturesJAMA, 2000
- HMG-CoA Reductase Inhibitors and the Risk of Hip Fractures in Elderly PatientsJAMA, 2000
- Do Statins Prevent Both Cardiovascular Disease and Fracture?JAMA, 2000
- Compactin and Simvastatin, but Not Pravastatin, Induce Bone Morphogenetic Protein-2 in Human Osteosarcoma CellsBiochemical and Biophysical Research Communications, 2000
- Bone morphogenetic proteins in human bone regenerationEuropean Journal of Endocrinology, 2000
- Stimulation of Bone Formation in Vitro and in Rodents by StatinsScience, 1999
- Current and future treatment of hyperlipidemia: the role of statinsThe American Journal of Cardiology, 1998